As a Coordinator at the International Unit of the Health Intervention and Technology Assessment Program (HITAP), Piyaphat supports regional and global initiatives that strengthen health systems through evidence-informed policymaking. With a background in liberal arts and professional experience across the humanitarian, public, and private sectors,

Picharee Karunayawong is a researcher and economist at the Health Intervention and Technology Assessment Program Foundation (HITAP). Her work focuses on data-driven and quantitative research aimed at improving the efficiency of national health systems and reducing the use of low-value care. She works closely with the policymakers, participating in

HTAsiaLink 20188-11 May 2018, Chiang Mai, ThailandMore than 200 participants from over 30  HTA organizations and other academic and policy making agencies across the global joined this conference!The themes of this years’ conference is Testing Treatments: Strengthening HTA for better healthcare.For

In early 2019, the Philippines passed a Universal Health Coverage (UHC) Act that automatically enrolls all Filipino citizens in a national health insurance scheme under the Philippine Health Insurance Corporation (PhilHealth). P0F0F1 P Their aim, to improve the breadth and depth of healthcare cove

Senegalese delegation with Dr. Yot Teerawattananon, Dr. Wanrudee Isaranuwatchai and Aparna Ananthakrishnan from HITAP We are very honored to have participated in the Health Technology Assessment (HTA) training and symposium.We have seen interestin

Parntip Juntama is a Researcher at HITAP specializing in Health Technology Assessment (HTA) and Health Economics. Her work focuses on policy-related research that provides evidence to support healthcare policy decisions in Thailand.Research Focus:Parntip conducts research on various health policy topics to inform national public health strategies.

Panupong Chaowanasawat is an Associate at the Health Intervention and Technology Assessment Program (HITAP). He holds a Bachelor of Science in Public Health (Honors) with a minor in Global Health and Social Medicine from Wayne State University, USA. His academic and professional background reflects a strong commitment to public health research and

In response to the request from Indonesia’s Ministry of Health (MOH), World Health Organization, South East Asia Regional Office (WHO SEARO) commissioned the HITAP International Unit (HIU) to provide support for the Package of Essential Non-communicable (PEN) disease intervention evaluation. The evaluation is predicted to include qualitative anal

Waranya Rattanavipapong1, Alia Cynthia Gonzales Luz1,*, Suthasinee Kumluang1,Nunik Kusumawardani2 and Yot Teerawattananon1 Co-investigators: Dewi Indriani3, Priska Apsari Primastuti3, Lily Banonah Rivai4, Sri Idaiani2, Ully Adhie2, Thunyarat Anothaisintawee1, Sarocha Chootipongchaivat1, Kanlaya T

The use of off-label medicines is an unexplored area for healthcare priority setting, though it is common practice in countries and can have a significant positive or negative effect on health outcomes and the efficiency of health care systems. It is therefore important to have a rational an